Pneumothorax Emerging As A New Complication Of COVID-19, Fin
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
As many as 1 in 100 hospitalized COVID-19 patients may experience a pneumothorax, or punctured lung, according to a multicenter observational case series published in the European Respiratory Journal.

Pneumothorax and pneumomediastinum have both been noted to complicate cases of COVID-19 requiring hospital admission. Authors report the largest case series yet described of patients with both these pathologies that includes non-ventilated patients.

Cases were collected retrospectively from UK hospitals with inclusion criteria limited to a diagnosis of COVID-19 and the presence of either pneumothorax or pneumomediastinum. Details obtained from the medical record included demographics, radiology, laboratory investigations, clinical management and survival.

Results:
-- Seventy-one patients from 16 centres were included in the study, of whom 60 patients had pneumothoraces (six also with pneumomediastinum), whilst 11 patients had pneumomediastinum alone.
-- Two of these patients had two distinct episodes of pneumothorax, occurring bilaterally in sequential fashion, bringing the total number of pneumothoraces included to 62.
-- Clinical scenarios included patients who had presented to hospital with pneumothorax, patients who had developed pneumothorax or pneumomediastinum during their inpatient admission with COVID-19 and patients who developed their complication whilst intubated and ventilated, either with or without concurrent extracorporeal membrane oxygenation.
-- Survival at 28 days was not significantly different following pneumothorax or isolated pneumomediastinum.
-- The incidence of pneumothorax was higher in males. The 28-day survival was not different between the sexes.
-- Patients above the age of 70 had a significantly lower 28-day survival than younger individuals.

Conclusively, These cases suggest that pneumothorax is a complication of COVID-19. Pneumothorax does not seem to be an independent marker of poor prognosis and we encourage active treatment to be continued where clinically possible.

Source: https://erj.ersjournals.com/content/early/2020/09/03/13993003.02697-2020
Dr. S●●●●●●A R●Y and 5 others like this5 shares
Like
Comment
Share